
2023

September 21, 2023
Inclusivity at the forefront of our clinical trials

September 21, 2023
Sanofi CHC North America earns B Corp Certification

September 21, 2023
Pilot take-back programs for insulin pens launched in 2 European countries

June 1, 2023
Sanofi partnering with the Ghana Ministry of Health to improve affordable access to diabetes care

June 1, 2023
Sanofi capping its insulin to a $35 out-of-pocket costs in the U.S.

June 1, 2023
Net Zero towards 2045

March 9, 2023
Sanofi Global Health Unit impact fund first investment in Swipe RX

February 6, 2023
Transform the treatment of sleeping sickness

February 6, 2023